High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-06-18 13:32:07 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-2600(24)00189-9
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260024001899
其他信息:
出版社: Elsevier BV
作者: Jiayi Yu; Leilei Jiang; Lina Zhao; Xue Yang; Xiaomin Wang; Dan Yang; Minglei Zhuo; Hanxiao Chen; Wei Huang; Zhengfei Zhu; Min Zhang; Yipeng Song; Quanfu Li; Zhanshu Ma; Qifeng Wang; Yanli Qu; Rong Yu; Huiming Yu; Jun Zhao; Anhui Shi; Jiayi Yu; Leilei Jiang; Lina Zhao; Xue Yang; Xiaomin Wang; Dan Yang; Minglei Zhuo; Hanxiao Chen; Wei Huang; Zhengfei Zhu; Min Zhang; Yipeng Song; Quanfu Li; Zhanshu Ma; Qifeng Wang; Yanli Qu; Rong Yu; Huiming Yu; Li Chu; Yun Bai; Yidian Zhao; Jinghua Luo; WenLi Chen; Tao Gu; Shixin Liu; Jun Yang; Yiqun Wu; Jun Zhao; Anhui Shi
